Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance

Blood markers of endothelial activation (sVCAM-1, vWF: Ag) in patients with chronic hepatitis C in the presence of insulin resistance, metabolic syndrome and its components had been evaluated. The study included 69 patients with chronic hepatitis C with oligosymptomatic the disease. In one third of...

Full description

Bibliographic Details
Main Authors:	T. V. Antonova, M. A. Romanova, Yu. V. Lymar
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	chronic hepatitis c insulin resistance vascular cellular adhesion molecule-1 von willebrand factor
Online Access:	https://journal.niidi.ru/jofin/article/view/132

Similar Items

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
by: T V Antonova, et al.
Published: (2013-12-01)

The epitope of the antibody used in the REAADS VWF activity assay is quaternary
by: Alexander Tischer, et al.
Published: (2025-01-01)

Lower levels of vWF are associated with lower risk of cardiovascular disease
by: Pauline C. S. vanParidon, et al.
Published: (2022-10-01)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023-05-01)

Value of vWF-related indicators in the diagnosis of liver cirrhosis progression in patients with hepatitis B
by: YANG Mingkang, LIU Yu, XU Guanqun, WANG Jianbiao, WANG Xuefeng, LIANG Qian
Published: (2024-12-01)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01)

VAS2870 Inhibits Histamine-Induced Calcium Signaling and vWF Secretion in Human Umbilical Vein Endothelial Cells
by: Pavel V. Avdonin, et al.
Published: (2019-02-01)

Glycosylation changes of vWF in circulating extracellular vesicles to predict depression
by: Norihiro Yamada, et al.
Published: (2024-11-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF
by: Matthias F. Schneider, et al.
Published: (2020-09-01)

The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model
by: Yathreb Asaad, et al.
Published: (2019-07-01)

Association of Ang-2, vWF, and EVLWI with risk of mortality in sepsis patients with concomitant ARDS: A retrospective study
by: Shuang Ma, et al.
Published: (2020-05-01)

Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
by: Samuel Wan Ki Wong, et al.
Published: (2023-09-01)

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
by: Ellen M. K. Warlo, et al.
Published: (2017-11-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
by: Jessica Garcia, et al.
Published: (2020-01-01)

A Comparison of Endothelial Cell-Selective Adhesion Molecule and von Willebrand Factor Expression in Breast Cancer Growth and Metastasis
by: M Husni Cangara, et al.
Published: (2018-04-01)

Markers of endothelial activation in rheumatoid arthritis
by: N P Shilkina, et al.
Published: (2012-08-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-01-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)

Endothelial damage and circadian blood pressure profile in rheumatoid arthritis
by: N P Shilkina, et al.
Published: (2019-05-01)

Bilirubin Prevents Atherosclerotic Lesion Formation in Low‐Density Lipoprotein Receptor‐Deficient Mice by Inhibiting Endothelial VCAM‐1 and ICAM‐1 Signaling
by: Megan E. Vogel, et al.
Published: (2017-04-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Exposure–Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD
by: Frank W.G. Leebeek, et al.
Published: (2024-04-01)

Phenotypic and Genotypic Signatures of VWF Exon 18 in Eastern Saudi Patients Previously Diagnosed with Type 1 von Willebrand Disease
by: Alzahrani FM, et al.
Published: (2022-06-01)

SpAD Biofunctionalized Cellulose Acetate Scaffolds Inhibit <i>Staphylococcus aureus</i> Adherence in a Coordinating Function with the von Willebrand A1 Domain (vWF A1)
by: Stefanos Pendas, et al.
Published: (2022-02-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis
by: Alexandros Makis, et al.
Published: (2017-01-01)

The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients
by: Kiruphagaran Thangaraju, et al.
Published: (2022-01-01)

Riociguat inhibits ultra‐large VWF string formation on pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension patients
by: Takayuki Jujo Sanada, et al.
Published: (2022-10-01)

Study Of Relationship Between Circulating Endothelial Cell Numbers And Plasma VWF Levels With Other Hematologic Findings In Patient With Chronic Lymphocytic Leukemia
by: Samaneh Heidarpourian, et al.
Published: (2016-02-01)

Study Of Relationship Between Circulating Endothelial Cell Numbers And Plasma VWF Levels With Other Hematologic Findings In Patient With Chronic Lymphocytic Leukemia
by: Samaneh Heidarpourian, et al.
Published: (2016-02-01)

Multiple Sclerosis Diagnosed in a Woman With Von-Willebrand Disease: A Case Report
by: Mohsen Farjoud Kouhanjani, et al.
Published: (2022-07-01)

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
by: Pikta Marika, et al.
Published: (2021-01-01)

The Effect of Eight Weeks of Continuous Endurance Training on ICAM-1 and VCAM-1 Expression in the Heart Tissue of Rats
by: MR Asad, et al.
Published: (2019-12-01)

Flaxseed Prevents Leukocyte and Platelet Adhesion to Endothelial Cells in Experimental Atherosclerosis by Reducing sVCAM-1 and vWF
by: Raluca Ecaterina Haliga, et al.
Published: (2013-01-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021-04-01)

B-Cell Activating Factor Increases Related to Adiposity, Insulin Resistance, and Endothelial Dysfunction in Overweight and Obese Subjects
by: Diana Carolina Villalpando Sánchez, et al.
Published: (2022-04-01)

Immunohistochemical study of Von Willebrand’s factor as a marker of endothelial dysfunction of utero-placental area and myometrium in pregnancy
by: Olena A. TIULIENIEVA, et al.
Published: (2019-09-01)

Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIbα—VWF interaction
by: Hosam Alden Baksamawi, et al.
Published: (2023-04-01)